Trade Names: | |
Synonyms: | |
Status: | Approved (2003) |
Entry Type: | Small molecule |
Molecule Category: | Salt |
UNII: | 75046A1XTN |
Parent Compound: | ALFUZOSIN |
InChI Key | YTNKWDJILNVLGX-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C19H28ClN5O4 |
Molecular Weight | 425.92 |
AlogP | 1.35 |
Hydrogen Bond Acceptor | 8.0 |
Hydrogen Bond Donor | 2.0 |
Number of Rotational Bond | 8.0 |
Polar Surface Area | 111.83 |
Molecular species | NEUTRAL |
Aromatic Rings | 2.0 |
Heavy Atoms | 28.0 |
Action | Mechanism of Action | Reference |
---|---|---|
AGONIST | Adrenergic receptor alpha-1 agonist | DailyMed |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Prostatic Hyperplasia | 4 | D011470 | ClinicalTrials |
Kidney Calculi | 3 | D007669 | ClinicalTrials |
Ureterolithiasis | 3 | D053039 | ClinicalTrials |
Resources | Reference |
---|---|
ChEBI | 32286 |
ChEMBL | CHEMBL1723 |
EPA CompTox | DTXSID3045514 |
FDA SRS | 75046A1XTN |
Guide to Pharmacology | 7109 |
KEGG | D07124 |
PubChem | 71764 |
SureChEMBL | SCHEMBL179910 |
ZINC | ZINC01843099 |